Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBT-004 for Vascularized Pinguecula
NCT04884256Phase 2Completed
- Sponsor
- Cloudbreak Pharma
- Start
- Dec 2023
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of axitinib in pinguecula, sponsored by Cloudbreak Pharma. Started Dec 2023; status: completed.
02
Drugs
axitinib
03
Conditions
pinguecula
Beyond the preview
Go deeper on NCT04884256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04884256.